CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- 4 Other disposition 10% owner disposed of 598,533 shares (other)
- 4 Other disposition Director disposed of 598,533 shares (other)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Grant or award Chief Development Officer acquired 21,576 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 35,702 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 20,047 shares (grant or award)
- 4 Grant or award President and Head of R&D acquired 80,365 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 179,169 shares (grant or award)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change
- 4 Open-market sale Chief Medical Officer sold 2,177 shares at $10.62 ($23,120)
- 4 Open-market sale Chief Development Officer sold 176 shares at $10.62 ($1,869)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Grant or award Director acquired 9,459 shares (grant or award)
- 4 Grant or award Director acquired 9,459 shares (grant or award)
- 4 Grant or award Director acquired 9,459 shares (grant or award)
Page 17 of 32 · 631 filings